| A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling J Qian, S Olbrecht, B Boeckx, H Vos, D Laoui, E Etlioglu, E Wauters, ... Cell research 30 (9), 745-762, 2020 | 492 | 2020 |
| Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization AR Pombo Antunes, I Scheyltjens, F Lodi, J Messiaen, A Antoranz, ... Nature neuroscience 24 (4), 595-610, 2021 | 376 | 2021 |
| Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity L Vanderbeke, P Van Mol, Y Van Herck, F De Smet, S Humblet-Baron, ... Nature communications 12 (1), 4117, 2021 | 217 | 2021 |
| CD4+ T cell-induced inflammatory cell death controls immune-evasive tumours B Kruse, AC Buzzai, N Shridhar, AD Braun, S Gellert, K Knauth, J Pozniak, ... Nature 618 (7967), 1033-1040, 2023 | 86 | 2023 |
| Network-based technologies for early drug discovery C Fotis, A Antoranz, D Hatziavramidis, T Sakellaropoulos, ... Drug discovery today 23 (3), 626-635, 2018 | 86 | 2018 |
| Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop Y Hua, G Vella, F Rambow, E Allen, AA Martinez, M Duhamel, A Takeda, ... Cancer Cell 40 (12), 1600-1618. e10, 2022 | 73 | 2022 |
| Functional heterogeneity of lymphocytic patterns in primary melanoma dissected through single-cell multiplexing FM Bosisio, A Antoranz, Y van Herck, MM Bolognesi, L Marcelis, ... Elife 9, e53008, 2020 | 48 | 2020 |
| Computerised scoring protocol for identification and quantification of different immune cell populations in breast tumour regions by the use of QuPath software L Berben, H Wildiers, L Marcelis, A Antoranz, F Bosisio, S Hatse, G Floris Histopathology 77 (1), 79-91, 2020 | 44 | 2020 |
| Transcriptional and spatial profiling of the kidney allograft unravels a central role for FcyRIII+ innate immune cells in rejection B Lamarthée, J Callemeyn, Y Van Herck, A Antoranz, D Anglicheau, ... Nature communications 14 (1), 4359, 2023 | 39 | 2023 |
| In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapy L Marcelis, A Antoranz, AM Delsupehe, P Biesemans, JF Ferreiro, ... Cancer Immunology, Immunotherapy 69, 1751-1766, 2020 | 38 | 2020 |
| Age‐related remodelling of the blood immunological portrait and the local tumor immune response in patients with luminal breast cancer L Berben, G Floris, C Kenis, B Dalmasso, A Smeets, H Vos, P Neven, ... Clinical & translational immunology 9 (10), e1184, 2020 | 35 | 2020 |
| Multiomics and spatial mapping characterizes human CD8+ T cell states in cancer S Naulaerts, A Datsi, DM Borras, A Antoranz Martinez, J Messiaen, ... Science Translational Medicine 15 (691), eadd1016, 2023 | 34 | 2023 |
| Multiplexed immunohistochemistry and digital pathology as the foundation for next-generation pathology in melanoma: methodological comparison and future clinical applications Y Van Herck, A Antoranz, MD Andhari, G Milli, O Bechter, F De Smet, ... Frontiers in oncology 11, 636681, 2021 | 34 | 2021 |
| SOX10 is as specific as S100 protein in detecting metastases of melanoma in lymph nodes and is recommended for sentinel lymph node assessment A Szumera-Ciećkiewicz, F Bosisio, P Teterycz, A Antoranz, F Delogu, ... European Journal of Cancer 137, 175-182, 2020 | 32 | 2020 |
| Mechanism-based biomarker discovery A Antoranz, T Sakellaropoulos, J Saez-Rodriguez, LG Alexopoulos Drug discovery today 22 (8), 1209-1215, 2017 | 31 | 2017 |
| Mapping the immune landscape in metastatic melanoma reveals localized cell–cell interactions that predict immunotherapy response A Antoranz, Y Van Herck, MM Bolognesi, SM Lynch, A Rahman, ... Cancer research 82 (18), 3275-3290, 2022 | 29 | 2022 |
| Next-generation pathology using multiplexed immunohistochemistry: mapping tissue architecture at single-cell level FM Bosisio, Y Van Herck, J Messiaen, MM Bolognesi, L Marcelis, ... Frontiers in oncology 12, 918900, 2022 | 29 | 2022 |
| A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanoma J Pozniak, D Pedri, E Landeloos, Y Van Herck, A Antoranz, ... Cell 187 (1), 166-183. e25, 2024 | 28 | 2024 |
| Next-generation pathology by multiplexed immunohistochemistry F De Smet, AA Martinez, FM Bosisio Trends in Biochemical Sciences 46 (1), 80-82, 2021 | 27 | 2021 |
| A fully defined matrix to support a pluripotent stem cell derived multi-cell-liver steatohepatitis and fibrosis model M Kumar, B Toprakhisar, M Van Haele, A Antoranz, R Boon, F Chesnais, ... Biomaterials 276, 121006, 2021 | 25 | 2021 |
Francesca Maria BosisioAssociate Professor, Dermatopathology and Melanoma Research, Single Cell Institute, KU Leuven在 kuleuven.be 的电子邮件经过验证
